Lyell Immunopharma Inc.
0.61
0.04 (6.18%)
At close: Jan 15, 2025, 2:39 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 145.65M 123.55M 293.83M 140.41M 96.67M
Short-Term Investments 400.58M 516.60M 320.97M 472.21M 339.38M
Long-Term Investments 48.51M 115.04M 330.53M 163.44M 68.98M
Other Long-Term Assets 4.52M 4.96M 3.95M 3.23M 2.68M
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 8.46M 11.14M 22.98M 4.93M 8.42M
Total Current Assets 554.69M 651.29M 626.29M 617.55M 440.26M
Property-Plant & Equipment 142.32M 166.26M 166.64M 124.06M 43.70M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 195.34M 286.27M 501.12M 290.73M 115.37M
Total Assets 750.03M 937.56M 1.13B 908.28M 555.63M
Account Payables 4.82M 3.92M 3.21M 9.40M 2.84M
Deferred Revenue n/a 21.87M 4.99M 6.09M 4.51M
Short-Term Debt 6.27M 4.53M 1.17M 3.62M 344.00K
Other Current Liabilities 23.43M 28.58M 37.37M 30.18M 14.35M
Total Current Liabilities 34.52M 37.03M 46.74M 49.28M 22.05M
Long-Term Debt 56.89M 126.34M 133.30M 50.96M 27.13M
Other Long-Term Liabilities 3.66M -59.05M -62.08M 532.00K n/a
Total Long-Term Liabilities 60.56M 67.28M 150.88M 140.56M 125.53M
Total Liabilities 95.08M 104.31M 197.62M 189.84M 147.58M
Total Debt 63.17M 67.70M 67.82M 54.57M 27.47M
Common Stock 25.00K 25.00K 24.00K 2.00K 1K
Retained Earnings -1.00B -767.48M -584.36M -334.14M -129.67M
Comprehensive Income -94.00K -7.60M -1.62M 256.00K 454.00K
Shareholders Equity 654.95M 833.25M 929.79M 718.44M 408.06M
Total Investments 449.08M 631.64M 651.50M 635.66M 408.36M

Create Price Alert on LYEL

Your price alert will notify you when the stock price is above 0.61.

Add to Watchlist